(Q37997180)

26 August 2017

Insulin resistance: a significant risk factor of endometrial cancer (English)

1 reference

26 August 2017

0 references

1 reference

1 reference

3

Yingmei Wang

1 reference

26 August 2017

Nan Mu

1

1 reference

26 August 2017

Yuanxi Zhu

series ordinal

2

1 reference

26 August 2017

Huiying Zhang

series ordinal

4

1 reference

26 August 2017

Fengxia Xue

series ordinal

5

1 reference

26 August 2017

language of work or name

English

0 references

publication date

23 March 2012

1 reference

26 August 2017

1 reference

26 August 2017

125

1 reference

26 August 2017

3

1 reference

26 August 2017

751-757

1 reference

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

26 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Insulin resistance and hyperinsulinaemia in the development and progression of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Insulin resistance, its consequences for the clinical course of the disease, and possibilities of correction in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Effect of Adiposity and Fat Distribution on Endometrial Cancer Risk in Shanghai Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Weight history and risk of endometrial cancer among Chinese women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Obesity, diabetes, and other factors in relation to survival after endometrial cancer diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Diabetes mellitus and risk of endometrial cancer: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case-control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Metabolic syndrome and endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

The association between metabolic abnormality and endometrial cancer: a large case-control study in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Risk factors in women 40 years of age and younger with endometrial carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Risk factors for young premenopausal women with endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Endometrial cancer in young, normal-weight women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Clinicopathological features in endometrial carcinoma associated with Lynch syndrome in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Inflammatory pathways and insulin action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

TNF-alpha induction of lipolysis is mediated through activation of the extracellular signal related kinase pathway in 3T3-L1 adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Cellular mechanisms of insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

The metabolic syndrome: metabolic changes with vascular consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Macrophages, inflammation, and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

A prospective study of inflammation markers and endometrial cancer risk in postmenopausal hormone nonusers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Androgen and estrogen metabolism: relationship to obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Molecular basis for the aromatization reaction and exemestane-mediated irreversible inhibition of human aromatase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Expression of adiponectin receptors and its possible implication in the human endometrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Chronic central leptin infusion modifies the response to acute central insulin injection by reducing the interaction of the insulin receptor with IRS2 and increasing its association with SOCS3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Effect of leptin and insulin resistance on properties of human monocytes in lean and obese healthy participants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Involvement of signaling molecules on na/h exchanger-1 activity in human monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Leptin induces functional activation of cyclooxygenase-2 through JAK2/STAT3, MAPK/ERK, and PI3K/AKT pathways in human endometrial cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Relationship between resistin and aPAI-1 levels with insulin resistance in Saudi children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Plasminogen activator inhibitor type 1 (PAI-1) is a valuable biomarker for predicting the metabolic syndrome (MS) in institutionalized elderly residents in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Clinical relevance of urokinase-type plasminogen activator, its receptor, and its inhibitor type 1 in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Interplay between insulin resistance and estrogen deficiency as co- activators in carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

The association of menstrual and reproductive factors with upper gastrointestinal tract cancers in the NIH-AARP cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Pregnancy and the risk of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Ageing and the response of plasma insulin, glucose and C-peptide concentrations to intravenous glucose in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Structure and function of phosphatidylinositol-3,4 kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Insulin signal transduction in normal cells and its role in carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Combined PTEN and p27kip1 protein expression patterns are associated with obesity and prognosis in endometrial carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase alpha-subunits in heart via hierarchical phosphorylation of Ser485/491.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

TSC2 mediates cellular energy response to control cell growth and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

AMPK phosphorylation of raptor mediates a metabolic checkpoint

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Loss of tuberous sclerosis complex-2 function and activation of mammalian target of rapamycin signaling in endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Autocrine stimulation of IGF1 in estrogen-induced growth of endometrial carcinoma cells: involvement of the mitogen-activated protein kinase pathway followed by up-regulation of cyclin D1 and cyclin E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Insulin receptor/IGF-I receptor hybrids are widely distributed in mammalian tissues: quantification of individual receptor species by selective immunoprecipitation and immunoblotting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Insulin-like growth factors and neoplasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Molecular mechanism of a cross-talk between oestrogen and growth factor signalling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Dose-dependent insulin regulation of insulin-like growth factor binding protein-1 in human endometrial stromal cells is mediated by distinct signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Crosstalk between IGF1R and estrogen receptor signaling in breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Endometrial cancer and the IGF system: a case-control study in Greece.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Association between Components of the Insulin-Like Growth Factor System and Endometrial Cancer Risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Circulating steroid hormone concentrations in postmenopausal women in relation to body size and composition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Sex hormone concentrations in post-menopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Polycystic ovary syndrome and endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Reproductive health and polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

The link between female infertility and cancer: epidemiology and possible aetiologies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Association between adiponectin, insulin resistance, and endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Circulating adiponectin and endometrial cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Insulin and endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

AMP-activated protein kinase: Role in metabolism and therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Metformin: a therapeutic opportunity in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Metformin is a potent inhibitor of endometrial cancer cell proliferation--implications for a novel treatment strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Treatment of atypical endometrial hyperplasia with an insulin-sensitizing agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Metformin: a potential novel endometrial cancer therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

Insulin therapy and colorectal adenoma risk among patients with Type 2 diabetes mellitus: a case-control study in Korea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.03.032

10.1016/J.YGYNO.2012.03.032

7 January 2021

Identifiers

DOI

1 reference

26 August 2017

1 reference